Marites Macasadia
Medical · National City, CANPI 1093743015
Payments from drug & device makers
Across 524 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Daiichi Sankyo Inc.$2K
- Amgen$1K
- AbbVie$839
- Boehringer Ingelheim$639
- Lilly USA, LLC$545
- plus $3K from 30 others
What the payments were for
- Food & beverage$10,14399%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 129 | $2,005 |
| Daiichi Sankyo Inc. | 144 | $1,680 |
| Amgen | 61 | $1,050 |
| AbbVie | 28 | $839 |
| Boehringer Ingelheim | 24 | $639 |
| Lilly USA, LLC | 29 | $545 |
| AstraZeneca | 13 | $418 |
| Boston Scientific | 6 | $336 |
| Edwards Lifesciences | 2 | $313 |
| Astellas Pharma US Inc | 8 | $308 |
| Gilead | 8 | $290 |
| Xeris Pharmaceuticals, Inc. | 13 | $280 |
| Bayer | 6 | $221 |
| GSK | 5 | $214 |
| Dexcom, Inc. | 5 | $197 |
| Pfizer | 8 | $167 |
| Amarin Pharma, Inc. | 5 | $94 |
| Hologic Sales And Service, LLC | 2 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $70 |
| Tempus AI, Inc | 2 | $51 |
| Phadia US Inc. | 3 | $46 |
| Merck | 2 | $46 |
| Heartflow, Inc. | 1 | $45 |
| Cranial Technologies, Inc | 3 | $44 |
| Johnson & Johnson | 2 | $34 |
| Exeltis, USA Inc. | 2 | $32 |
| Tris Pharma Inc | 1 | $22 |
| Novartis | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| Abbott | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Metacel Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$370
- Repatha$366
- Wegovy$365
- JARDIANCE$246
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$135
- QULIPTA$125
- Veozah$122
- AIRSUPRA$122
- Ozempic$122
- Yeztugo$121
- Watchman$118
- DEXCOM G7 GSS (161)$117
- GVOKE HYPOPEN$115
How this compares
$10,209 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 115 | $129,801 |
| JardianceEmpagliflozin | 60 | $67,857 |
| JanuviaSitagliptin Phosphate | 32 | $38,749 |
| TrulicityDulaglutide | 30 | $34,752 |
| EliquisApixaban | 26 | $32,576 |
| LinzessLinaclotide | 35 | $26,401 |
| RybelsusSemaglutide | 17 | $22,363 |
| FarxigaDapagliflozin Propanediol | 19 | $17,741 |
| Tresiba Flextouch U-200Insulin Degludec | 27 | $16,604 |
| MounjaroTirzepatide | 11 | $13,024 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $8,785 |
| Atorvastatin Calcium | 381 | $3,522 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 102 | $3,208 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,150 |
| Omeprazole | 93 | $1,734 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $2,005 | $152,164132 claims |
| Boehringer IngelheimJardiance | $639 | $67,85760 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $545 | $47,77641 claims |
| MerckJanuvia | $46 | $38,74932 claims |
| PfizerEliquis | $167 | $32,57626 claims |
| AbbVieLinzess | $839 | $26,40135 claims |
| AstraZenecaFarxiga | $418 | $17,74119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in National City
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.